Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.77B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.52B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.18B |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$947M |
| 5 |
Zoetis
ZTS
|
+$787M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.39B |
| 2 |
NVIDIA
NVDA
|
+$2.32B |
| 3 |
Microsoft
MSFT
|
+$2.06B |
| 4 |
Apple
AAPL
|
+$1.62B |
| 5 |
Vanguard Total Bond Market
BND
|
+$1.51B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.47% |
| 2 | Financials | 11.66% |
| 3 | Consumer Discretionary | 8.63% |
| 4 | Communication Services | 7.31% |
| 5 | Healthcare | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
PAR Technology
PAR
$695M
| $12.3M | ﹤0.01% |
177,328
-51,789
| -23% | -$3.24M |
|
3227
Perimeter Solutions
PRM
$6.07B
| $12.3M | ﹤0.01% |
881,665
-166,986
| -16% | -$1.93M |
|
3228
Invesco Biotechnology & Genome ETF
PBE
$286M
| $12.3M | ﹤0.01% |
191,173
-1,680
| -0.9% | -$104K |
|
3229
iShares Global Materials ETF
MXI
$346M
| $12.2M | ﹤0.01% |
143,290
+7,448
| +5% | +$617K |
|
3230
Excelerate Energy
EE
$1.22B
| $12.2M | ﹤0.01% |
417,226
+184,749
| +79% | +$5.18M |
|
3231
GS ActiveBeta US Small Cap Equity ETF
GSSC
$1.05B
| $12.2M | ﹤0.01% |
178,181
+19,075
| +12% | +$1.22M |
|
|
GRVY
3232
GRAVITY
GRVY
$430M
| $12.2M | ﹤0.01% |
191,873
-5,994
| -3% | -$372K |
|
3233
WisdomTree International SmallCap Dividend Fund
DLS
$1.06B
| $12.2M | ﹤0.01% |
162,461
-2,881
| -2% | -$202K |
|
3234
Red Cat Holdings
RCAT
$1.12B
| $12.2M | ﹤0.01% |
1,675,659
+1,179,964
| +238% | +$7.7M |
|
3235
Compass Minerals
CMP
$1.25B
| $12.2M | ﹤0.01% |
606,800
+45,921
| +8% | +$742K |
|
3236
iShares Global Industrials ETF
EXI
$1.41B
| $12.2M | ﹤0.01% |
73,612
+41,610
| +130% | +$6.38M |
|
3237
Gogo Inc
GOGO
$559M
| $12.2M | ﹤0.01% |
828,915
-355,204
| -30% | -$3.61M |
|
3238
Nabors Industries
NBR
$1.22B
| $12.2M | ﹤0.01% |
434,092
+76,065
| +21% | +$2.26M |
|
3239
PDF Solutions
PDFS
$1.93B
| $12.1M | ﹤0.01% |
567,701
+115,528
| +26% | +$2.19M |
|
3240
Xenon Pharmaceuticals
XENE
$6.2B
| $12.1M | ﹤0.01% |
387,596
+258,105
| +199% | +$8.42M |
|
3241
First Trust Mid Cap Value AlphaDEX Fund
FNK
$229M
| $12.1M | ﹤0.01% |
234,184
+6,880
| +3% | +$338K |
|
3242
Hallador Energy
HNRG
$689M
| $12.1M | ﹤0.01% |
765,072
+577,664
| +308% | +$8.93M |
|
3243
Willdan Group
WLDN
$1.06B
| $12.1M | ﹤0.01% |
193,568
+106,068
| +121% | +$5.06M |
|
3244
Invesco S&P International Developed Low Volatility ETF
IDLV
$349M
| $12.1M | ﹤0.01% |
364,889
+168,216
| +86% | +$5.38M |
|
3245
Nuveen ESG Emerging Markets Equity ETF
NUEM
$368M
| $12.1M | ﹤0.01% |
363,408
-8,461
| -2% | -$257K |
|
|
RDUS
3246
DELISTED
Radius Recycling
RDUS
| $12.1M | ﹤0.01% |
406,208
-72,109
| -15% | -$2.12M |
|
3247
Invesco Solar ETF
TAN
$1.43B
| $12.1M | ﹤0.01% |
352,019
-77,094
| -18% | -$2.42M |
|
3248
iShares MSCI Emerging Markets Asia ETF
EEMA
$826M
| $12M | ﹤0.01% |
145,803
-1,826
| -1% | -$139K |
|
3249
Perella Weinberg Partners
PWP
$1.09B
| $12M | ﹤0.01% |
618,449
+82,136
| +15% | +$1.45M |
|
3250
iShares US Pharmaceuticals ETF
IHE
$1.48B
| $12M | ﹤0.01% |
183,115
-28,869
| -14% | -$1.88M |
|
Similar funds
Morgan Stanley's Q2 2025 Portfolio in Review
As of Q2 2025, Morgan Stanley held 8,401 positions worth $1.54T, up 9.8% from $1.4T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2025 filing shows 313 new, 3,923 increased, 2,951 reduced and 306 closed positions. Its largest new stake was JBS N.V.: 7,554,358 shares worth $110M. The largest sale was UnitedHealth, an estimated $2.39B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q2 2025 buy was JBS N.V.: 7,554,358 shares worth $110M.
- Morgan Stanley added most to Vanguard Short-Term Bond ETF in Q2 2025, an estimated $1.77B increase.
- Morgan Stanley's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $2.39B.
- Morgan Stanley fully exited Discover Financial Services in Q2 2025, selling an estimated $786M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.54T portfolio in Q2 2025.
- Morgan Stanley opened 313 new positions and closed 306 in Q2 2025.
- Morgan Stanley's portfolio value rose 9.8% quarter-over-quarter to $1.54T.
Based on Morgan Stanley's 13F filing for Q2 2025, filed 15 Aug 2025.